TIDE/IPS-based predicted immunotherapy response

Biomarker

1 paper studies it1 finding

1 new paper in 30 daysSee all 1

  • Humans1

Associations

1

Senescence-related signatures

mixedin humans1

1 study
  1. Senescence-related signatures are associated with TIDE/IPS-based predicted immunotherapy response in humans.

    “more favorable Tumor Immune Dysfunction and Exclusion (TIDE)/immunophenoscore (IPS)-based predicted response profiles”

    Humanslow-SRS tumorsbreast tumor

    Tumor score linked to survival in breast cancer patients

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology

More on Senescence-related signatures

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 11 paper in 12 months
FASEB Journal

Tumor score linked to survival in breast cancer patients

An observational analysis of breast cancer data linked higher scores to poorer survival and lower scores to more favorable predicted immunotherapy responses.An observational analysis of breast cancer data linked higher scores to poorer survival and lower scores to more favorable predicted immunotherapy responses.

Cohort studyBreast cancer